Premature atherosclerosis in HIV positive patients and cumulated time of exposure to antiretroviral therapy (SHIVA study)

Atherosclerosis

Volumn 185, Issue 2, 2006, Pages 361-367

  Martin, Luc De Saint ^a   Vandhuick, Olivier ^b   Guillo, Philippe ^b   Bellein, Véronique ^a   Bressollette, Luc ^b   Roudaut, Nathalie ^b   Amaral, Antonio ^b   Pasquier, Elisabeth ^a  

^a SERVICE DE RHUMATOLOGIE   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Antiretroviral therapy; Atherosclerosis; Cardiovascular disease; HIV; Intima media thickness

Indexed keywords

ANTIRETROVIRUS AGENT; LOPINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG EXPOSURE; ECHOGRAPHY; ELECTROCARDIOGRAM; EXERCISE TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SCINTIGRAPHY; SCORING SYSTEM;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CAROTID ARTERY, COMMON; COHORT STUDIES; HIV PROTEASE INHIBITORS; HIV SEROPOSITIVITY; HUMANS; LIPIDS; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 33644500402     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.06.049     Document Type: Article

References (30)

1. D. Periard, A. Telenti, and P. Sudre Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors Circulation 100 1999 700 705
2. N. Friis-Moller, R. Weber, and P. Reiss Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study AIDS 17 2003 1179 1193
3. G. Barbaro, G. Di Lorenzo, and A. Cirelli An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy Clin Ther 25 9 2003 2405 2418
4. A. Tabib, C. Leroux, and J.F. Mornex Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients Coronary Artery Dis 11 2000 41 46
5. R. Talwani, O.M. Falusi, and C.F. Mendes de Leon Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy J Acq Immun Def Synd 30 2002 191 195
6. M. Depairon, S. Chessex, and P. Sudre Premature atherosclerosis in HIV-infected individuals-focus on protease inhibitor therapy AIDS 15 2001 329 334
7. J.S. Currier, A. Taylor, and F. Boyd Coronary heart disease in HIV-infected individuals J Acq Immun Def Synd 33 4 2003 506 512
8. G. Chironi, L. Escaut, and J. Gariepy Carotid intima-media thickness in heavily pretreated HIV-infected patients J Acq Immun Def Synd 32 5 2003 490 493
9. D. Vittecoq, L. Escaut, and G. Chironi Coronary heart disease in HIV-infected patients in the highly active antiretroviral treatment era AIDS 17 Suppl 1 2003 S70 S76
10. S.A. Bozzette, C.F. Ake, and H.K. Tam Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection N Engl J Med 348 2003 702 710
11. D. Klein, L.B. Hurley, and C.P. Quesenberry Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acq Immun Def Synd 30 2002 471 477
12. S.D. Holmberg, A.C. Moorman, and J.M. Williamson Protease inhibitors and cardiovascular outcomes in patients with HIV-1 Lancet 360 2002 1747 1748
13. P.Y. Hsue, J.C. Lo, and A. Franklin Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection Circulation 109 2004 1603 1608
14. P. Maggi, G. Serio, and Epifani GFG Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors AIDS 14 2000 123 128
15. P. Mercie, R. Thiebaut, and V. Lavignolle Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement Ann Med 34 2002 55 63
16. E. Seminari, A. Pan, and G. Voltini Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors Atherosclerosis 162 2002 433 438
17. P.W. Wilson, R.B. D'Agostino, and D. Levy Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
18. B. Balkau, M.A. Charles, and T. Drivsholm Frequency of the WHO metabolic syndrome in European cohorts and an alternative definition of an insulin resistance syndrome Diabetes Metab 28 2002 364 376
19. A. Aminbakhsh, and G.B. Mancini Carotid intima-media thickness measurements: what defines an abnormality? A systematic review Clin Invest Med 22 1999 149 157
20. C. Hadigan, J.B. Meigs, and P.W. Wilson Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution Clin Infect Dis 36 2003 909 916
21. N. Friis-Moller, C.A. Sabin, and R. Weber Combination antiretroviral therapy and the risk of myocardial infarction N Engl J Med 349 2003 1993 2003
22. P. Maggi, A. Lillo, and F. Perilli Colour-doppler ultrasonography of carotid vessels in patients treated with antiretroviral therapy a comparative study AIDS 18 2004 1023 1028
23. N. Demarié, J. Gariepy, and G. Chironi Distribution of ultrasonographically-assessed dimension of common carotid arteries in healthy adults of both sexes Atherosclerosis 148 2000 297 302
24. L.V. Chalifoux, M.A. Simon, and D.R. Pauley Arteriopathy in macaques infected with simian immunodeficiency virus Lab Invest 67 1992 338 349
25. T. Neumann, T. Woiwoid, and A. Neumann Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part I. Differences due to the acquisition of HIV-infection Eur J Med Res 8 2003 229 235
26. J. Ferrieres, A. Elias, and J.B. Ruidavets Carotid intima-media thickness and coronary heart disease factors in a low-risk population J Hypertens 17 1999 743 748
27. J. Minamikawa, S. Tanaka, and M. Yamauchi Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes J Clin Endocrinol Metab 83 1998 1818 1820
28. M. Duong, Y. Cottin, and L. Piroth Exercise stress testing for detection of silent myocardial ischemia in human immunodeficiency virus-infected patients receiving antiretroviral therapy Clin Infect Dis 34 2002 523 528
29. S.G. DAD Combination antiretroviral therapy and the risk of myocardial infarction N Engl J Med 349 2003 1993 2003
30. S. Lai, H. Lai, and D.D. Celentano Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors AIDS Patient Care STDS 17 2003 211 219